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Abstract
In the treatment of orbital floor fractures, bone is ideally 
regenerated. The materials currently used for orbital floor 
reconstruction do not lead to the regeneration of bone. 
Our objective was to render polymeric materials based 
on poly(trimethylene carbonate) (PTMC) osteoinductive, 
and to evaluate their suitability for use in orbital floor 
reconstruction. For this purpose, osteoinductive biphasic 
calcium phosphate (BCP) particles were introduced into 
a polymeric PTMC matrix. Composite sheets containing 
50 wt% BCP particles were prepared. Also laminates with 
poly(D,L-lactide) (PDLLA) were prepared by compression 
moulding PDLLA films onto the composite sheets. After 
sterilisation by gamma irradiation, the sheets were used to 
reconstruct surgically-created orbital floor defects in sheep. 
The bone inducing potential of the different implants was 
assessed upon intramuscular implantation.
 The performance of the implants in orbital floor 
reconstruction was assessed by cone beam computed 
tomography (CBCT). Histological evaluation revealed 
that in the orbital and intramuscular implantations of BCP 
containing specimens, bone formation could be seen after 
3 and 9 months. Analysis of the CBCT scans showed that 
the composite PTMC sheets and the laminated composite 
sheets performed well in orbital floor reconstruction. It is 
concluded that PTMC/BCP composites and PTMC/BCP 
composites laminated with PDLLA have osteoinductive 
properties and seem suitable for use in orbital floor 
reconstruction.
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osteoinductive; orbital floor fracture; bone formation.
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Introduction
Orbital floor fractures are a common result of injury to 
the orbit. Herniation of orbital fat and/or entrapment 
of ocular muscle can be avoided by reconstructing the 
bony orbital floor. The use of autologous bone grafts 
is considered to be the ‘gold standard’ for repair and 
reconstruction of bony defects in orbital floor fractures. 
However, the method has several disadvantages among 
which are: the extra operation time, the accompanying 
donor-site morbidity and the poor predictability of 
the resorption rate of autologous bone (Giannoudis 
et al., 2005). To avoid these drawbacks, implants 
prepared from (non-resorbable) materials like titanium, 
polytetrafluoroethylene, polyethylene and silicone rubbers 
have been applied in the treatment of orbital floor fractures 
(Ellis and Messo, 2004; Prowse et al., 2010). Being able to 
use biodegradable and resorbable implant materials would 
be of great interest, as the use of permanent implants is 
associated with the life-long risk of infections. However, 
after degradation of biodegradable materials, the formed 
fibrous capsule that remains might not be sufficiently rigid 
to prevent late enophthalmos. This is especially relevant 
when reconstructing large orbital floor defects (Kontio 
et al., 2004; Jaquiery et al., 2007; Kontio and Lindqvist, 
2009). New bone formation during healing of the fractured 
orbit would therefore be highly desirable. Poly(lactide)s 
and poly(glycolide)s are biodegradable polymers that 
have most often been investigated (Eppley and Prevel, 
1997; Potter and Ellis, 2004). Upon degradation of these 
polymers, however, acidic compounds are formed. These 
compounds can have a detrimental effect on surrounding 
(bone) tissues, and hinder the formation of new bone 
(Taylor et al., 1994; Wu and Ding, 2004).
 As a result of its osteogenic and osteoinductive 
properties, bone formation in orbital floor reconstruction 
currently only occurs when autologous bone is used. To 
obtain a synthetic implant material that leads to formation 
of bone in bony defects, osteoinductive or osteoconductive 
properties are required. It has been shown in several animal 
studies, that calcium phosphate ceramics with specific 
surface microstructures have osteoinductive properties 
(Malard et al., 1999; Ripamonti, 1996; Le Nihouannen 
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et al., 2005; Habibovic et al., 2006; Fellah et al., 2008; 
Fellah et al., 2010; Yuan et al., 2010). Unfortunately, these 
(sintered) ceramic materials are brittle and difficult to 
obtain in a specific shape. To overcome these drawbacks, 
composite materials have been prepared by introducing the 
calcium phosphates into polymeric matrices (Greish and 
Brown, 2001; Ignatius et al., 2001; Kikuchi et al., 2002; 
Guan and Davies, 2004; Dorozhkin, 2009). This was shown 
to improve both mechanical and handling properties. 
Hence, composite materials based on bone-inducing 
microstructured biphasic calcium phosphate (BCP) and a 
polymeric matrix of poly(trimethylene carbonate) (PTMC) 
seem interesting.
 PTMC is an amorphous polymer with a relatively low 
elastic modulus of 5 to 7 MPa at room temperature. PTMC 
degrades enzymatically in vivo by a surface erosion process 
without the formation of acidic degradation products 
(Pego et al., 2003b; Zhang et al., 2006). The polymer has 
not been shown to calcify or lead to the formation of new 
bone upon implantation. Furthermore, it has been shown 
that PTMC does not exert negative effects on bone (such 
as osteolysis) and ocular tissue (Habraken et al., 2008; 
Jansen et al., 2011; Liao et al., 2011).
 We recently prepared composite materials consisting 
of PTMC and calcium phosphate ceramics (Van Leeuwen 
et al., 2012b) and described their mechanical properties. 
It was shown that incorporation of calcium phosphate 
particles increased the flexural modulus of the composite.
 It is hypothesised that the composite materials will have 
osteoinductive properties as the BCP will become exposed 
during degradation of the PTMC matrix.
 This paper describes the preparation and in vivo 
evaluation of composite materials based on microstructured 
BCP and PTMC. Although implant materials with 
(relatively) low elasticity modulus values such as silicone 
have been quite effective in reconstructing (small) orbital 
floor defects (Prowse et al., 2010), the reconstruction 
of large defects might necessitate the use of more rigid 
materials. To allow the reconstruction of large orbital 
floor defects, we also prepared laminates of the composite 
materials with a single thin layer of poly(D,L-lactide) 
(PDLLA). In preparing these structures, however, we 
ensured that the PDLLA component was in minimal contact 
with the calcium phosphate particles, and that only small 
amounts of PDLLA are used. This has been described in 
more detail in previous work (Van Leeuwen et al., 2012b).
Materials and Methods
Materials
Polymerisation grade 1,3-trimethylene carbonate (TMC) 
was obtained from Boehringer Ingelheim, Germany. 
Stannous octoate (SnOct2 from Sigma-Aldrich, St. Louis, 
MO, USA) was used as received. High molecular weight 
poly(D,L-lactide) (PDLLA, with a 50/50 molar ratio 
of L- to D-lactide) was obtained from Purac Biochem, 
(Gorinchem, The Netherlands), and used as received.
 Biphasic calcium phosphate ceramic, (20 ±3 wt% 
beta-tricalcium phosphate (β-TCP) and 80 ±3 wt% 
hydroxyapatite (HA)), which was sintered at 1150 °C for 
8 h and sieved to particle sizes 45-150 µm according to 
Habibovic et al. (Habibovic et al., 2006), was obtained 
from Xpand Biotechnology (Bilthoven, The Netherlands).
 The BCP particles exhibited a surface microstructure 
that results from the surface microporosity and the 
small grain size of the particles (Yuan et al., 1999). The 
particles had a microporosity of 17 % and a specific 
surface of 1.0 m2/g. The used solvents were of technical 
grade and purchased from Biosolve (Valkenswaard, The 
Netherlands).
Preparation of composites and laminates
Poly(trimethylene carbonate) (PTMC) was prepared by 
ring opening polymerisation of trimethylene carbonate at 
130 °C for a period of 3 days. Stannous octoate was used 
as a catalyst at a concentration of 2x10-4 mol per mol of 
monomer. Analysis of the synthesised polymer by proton 
nuclear magnetic resonance (1H-NMR), gel permeation 
chromatography (GPC) and differential scanning 
calorimetry (DSC) according to procedures described 
earlier (Pego et al., 2003a) indicated that high molecular 
weight polymer had been synthesised. GPC measurements 
showed that Mw = 414,000 g/mol and Mn = 316,000 g/
mol, while nuclear magnetic resonance (NMR) indicated 
that monomer conversion was more than 98 %.
 The glass transition temperature of this amorphous 
polymer was approximately -17 °C, as thermal analysis 
showed (Pego et al., 2003a).
 The PTMC polymer was purified by dissolving in 
chloroform and precipitation into an excess of ethanol. 
Similarly, composites of PTMC with BCP particles 
were prepared by dissolving PTMC in chloroform at a 
concentration of 5 g/100 mL, after which the BCP was 
added and dispersed in the solution by magnetic stirring. 
The uniform dispersion was then precipitated into a five-
fold excess of ethanol 100 %. The composite precipitate 
was collected and dried under vacuum at room temperature 
until constant weight was reached. PTMC/BCP composites 
containing 50 wt% (corresponding to 30 vol%) of βTCP 
were prepared.
 After drying, the purified PTMC and the composite 
precipitate were compression moulded into 1.5 mm thick 
sheets at 140 °C and a pressure of 3.0 MPa using a Carver 
model 3851-0 laboratory press (Carver, Wabash, IN, USA). 
The poly(D,L-lactide) was also of high molecular weight, 
and had an Mw = 234,000 g/mol and an Mn = 178,000 g/
mol. NMR indicated that the residual monomer content was 
less than 1 %. The glassy polymer was also amorphous, and 
had a glass transition temperature of approximately 52 °C. 
This polymer was compression moulded into 0.3 mm thick 
sheets at 140 °C.
 Laminates of the PTMC/BCP composites and PDLLA 
were prepared by compression moulding PDLLA sheets 
onto sheets of the composite material at 140 °C. The 
PTMC/BCP composite layer was 1.2 mm thick, while the 
PDLLA layer was 0.3 mm thick.
 The prepared sheets were then sealed under vacuum and 
exposed to 25 kGy gamma irradiation from a 60Co source 
(Isotron, Ede, The Netherlands) for sterilisation.
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Experimental design of the animal study
All procedures performed on the animals were done 
according to international standards on animal welfare 
as well as being compliant with the Animal Research 
Committee of the University Medical Centre Groningen.
 Ten full-grown female Dutch Texel sheep were operated 
on and (evenly) divided into two groups. The first group 
had a follow-up of 3 months, the second a follow-up of 
9 months. Critical size defects measuring 2.5-3.0 cm2 
(Kontio et al., 2004) were created in both orbital floors 
and reconstructed with: (1) a PTMC sheet, (2) a composite 
(PTMC/BCP) sheet or (3) a laminated composite (PTMC/
BCP-PDLLA) sheet. Regarding the laminated composite, 
the PDLLA layer faced the maxillary sinus.
 To be able to distinguish between osteoinductivity and 
osteoconductivity, bone formation is generally evaluated 
in a non-bony environment (Urist, 1965; Urist et al., 
1967; Habibovic et al., 2006; Barradas et al., 2011). To 
assess osteoinductive properties of our materials, samples 
(1.5 mm x 10 mm diameter) of the prepared sheets, as 
well as 1 mL of the used BCP particles, were implanted 
intramuscularly in the back of the sheep.
 For the orbital floor implantations, multiple different 
materials were implanted in individual animals in a 
randomised manner. The same materials were also 
implanted intramuscularly. Furthermore, BCP was 
implanted intramuscularly in each animal as well. An 
overview of the performed implantations is provided in 
Table 1.
 To determine the position of the reconstructed orbital 
floor, all sheep were evaluated by cone-beam computed 
tomography (CBCT) 1 week before and 1 week after 
surgery, and at the time of termination. To monitor 
bone formation over time, fluorochrome markers were 
administered at 3, 6 and 9 weeks after surgery and at 30, 
33 and 36 weeks for respectively the 3 and the 9 month 
group. Bone formation was evaluated by histology and 
histomorphometry of non-decalcified sections using 
epifluorescent confocal and conventional light microscopy.
Surgical procedure and fluorochrome labelling
Ten adult full-grown female Dutch Texel sheep, aged 24-
36 months, were acquired and allowed to acclimatise for 
two weeks. The surgical procedures were performed under 
general anaesthesia. After the subciliar area was shaved 
and disinfected, both orbital floors were exposed using an 
infraorbital approach. The periosteum was elevated and 
the floor was fractured using a burr and/or a chisel. Bone 
fragments were removed from the defect site. The bony 
defects created were approximately circular measured 2.5-
3.0 cm2 in size. Then the orbital floor was reconstructed 
using one of the implant materials (PTMC, PTMC/BCP 
composite or laminated PTMC/BCP-PDLLA composite 
sheet). The size of the implant was cut with a pair of 
scissors to fit the orbit, while care was taken to ensure 
that the defect was completely covered. In this first study, 
implants were fixed with one titanium screw (1.5 x 3.5 mm, 
KLS-Martin, Tuttlingen, Germany) to prevent dislocation. 
After reconstruction, the orbital periosteum was incised to 
mimic a traumatic situation (the incision allowed the orbital 
fat and musculature to prolapse into the orbit). The wound 
was closed in layers with resorbable sutures (Polyglactin 
910, Ethicon, Johnson & Johnson, New Brunswick, 
NJ, USA). At the same time, samples were implanted 
intramuscularly in the paraspinal muscles. The muscle 
fascia was closed with non-resorbable sutures to mark the 
different implantation sites in the back (Polypropylene, 
Ethicon). The other layers were closed with resorbable 
sutures. Prior to surgery amoxicillin (15 mg/kg) was 
administered and continued for 6 days postoperative. 
Buprenorphin was administered for peri- and postoperative 
pain relief.
 Fluorochrome markers were administered at the 
previously mentioned time points prior to termination. 
Calcein Green (10 mg/kg intravenously, Sigma-Aldrich) 
was administered at 3 weeks and at 30 weeks, Xylenol 
Orange (100 mg/kg intravenously, Sigma-Aldrich) at 
6 weeks and at 33 weeks and Oxytetracyclin (Engemycine 
32 mg/kg intramuscularly, Mycofarm, Braintree, UK) 
at 9 weeks and at 36 weeks after surgery. NaHCO3 
and saline solutions were used as solvents. After 3 and 
9 months follow-up, the animals were sacrificed by 
injecting an overdose of pentobarbital (Organon, Oss, The 
Netherlands), and the implantation areas were retrieved 
and fixed in a 4 % phosphate-buffered formalin solution.
Histological preparation
The fixed samples were rinsed with phosphate buffered 
saline (PBS), dehydrated in a series of ethanol solutions 
(70 %, 80 %, 90 %, 96 %, 100 % x2) and embedded in 
methyl methacrylate (LTI, Bilthoven, The Netherlands). 
Using a modified diamond saw (Klein et al., 1994) 
(Leica SP1600, Leica Microsystems, Wetzlar, Germany), 
histological sections (10-20 µm thick) were made along 
the plane perpendicular to the orbital floor. The tissue 
samples of the intramuscularly implanted materials were 
sawed parallel to the long axis of the implants. Sections 
for light microscopy (Nikon Eclipse E200, www.nikon.
com) observation were stained with 1 % methylene blue 
(Sigma-Aldrich, The Netherlands) and 0.3 % basic fuchsin 
(Sigma-Aldrich) solutions. Sections for epifluorescent 
confocal laser microscopy (Leica TCS SP2, Leica, Wetzlar, 
Germany) observation were not stained. Epifluorescent 
data were collected with 20x oil immersion objective, 
including transmitted light detection. The peak absorption 
(abs.) and emission (em.) wavelengths were: 351/364 nm 
abs. and 560 nm em., 543 nm abs. and 580 nm em., 488 nm 
abs. and 517 nm em., for Tetracycline, Xylenol Orange 
Table 1: Overview of implantations and implantation 
sites for the experimental 3 and 9 month implantation 
groups.
Implantation material 3 months 9 months
BCP particles IM: n = 5 IM: n = 5
PTMC OF: n = 3 
IM: n = 3
OF: n = 3
IM: n = 3
PTMC/BCP composite OF: n = 4
IM: n = 4
OF: n = 4
IM: n = 4
PTMC/BCP-PDLLA 
laminated composite 
OF: n = 3
IM: n = 3
OF: n = 3
IM: n = 3
OF: orbital floor
IM: intramuscular
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and Calcein, respectively. These are the optimal settings. 
This means that, contrary to conventional fluorescent 
microscopy, the fluorescence colours of Oxytetracycline, 
Xylenol Orange and Calcein are blue, red and green, 
respectively. (Note that these settings also allow us to 
distinguish between the fluorescence of Tetracycline in 
blue and the co-localisation of Xylenol Orange and Calcein 
in yellow.
Histomorphometry and statistics
Images of the stained sections for histomorphometric 
analysis were made using a slide scanner (Dimage Scan 
Elite 5400 II, Konica Minolta Photo Imaging, www.
konicaminolta.com). Histomorphometry was performed 
using Adobe Photoshop Elements 4.0 software (Adobe, 
San Jose, CA, USA). From each animal, multiple sections 
were prepared for histomorphometric analysis. However, 
from each obtained explanted sample one section was 
prepared for histomorphometrical analysis. The prepared 
sections were taken from the centre of the implantations. 
Briefly, the implant area was selected as the region of 
interest (ROI) and the corresponding number of pixels 
registered. Then, both BCP particles and mineralised 
bone were pseudo-coloured and the resulting numbers of 
pixels used to calculate the percentage of bone formation 
in the available space (available space is defined as the 
space between the BCP particles assuming the polymer 
has resorbed) as:
       (1)
Averages and standard deviations were calculated for the 
percentage of bone formed in the available area.
Radiological examination
Cone-beam computed tomography (CBCT) scanning was 
performed preoperatively to assess the position of the 
orbital floor. The position of the reconstructed orbital floor 
was assessed postoperatively and at the time of termination. 
Scanning was carried out under general anaesthesia with 
propofol (1.5 mg/kg). The CBCT images were acquired 
with an i-CAT Scanner (i-CAT, Imaging Sciences 
International, Hatfield, PA, USA) with a 0.3 mm voxel size 
and a 170 mm field of view. Each scan was performed with 
the head of the animal in the same, reproducible position 
using the laser guide of the scanner as a reference.
 Using Mimics Software (Materialise Dental, Leuven, 
Belgium), 3-dimensional (3D) reconstructions of all 
individual scans were made. In each dataset, a threshold 
was applied to depict the bone. The preoperative (intact) 
orbital floors, and the postoperative reconstructed orbital 
floors (i.e., the orbital floor implants) and the reconstructed 
orbital floors at the time of termination, were then 
selected as region of interest (ROI). Using Geomagic 
Studio Software (Geomagic, Rock Hill, SC, USA), the 
3D reconstructed scans were aligned and registered with 
the preoperative 3D reconstructed scans using an iterative 
closest-point registration algorithm. The deviations 
between the datasets are presented using a sliding colour 
scale to visualise the differences between the surfaces of the 
orbital floors at the different time points (see for example 
Fig. 7). For each implant, the mean negative deformation 
at the location of the defect was calculated.
 The negative deformation of the different implants at 
the different time points was used to calculate the increase 
of the orbital volume using (Van Leeuwen et al., 2012a):
                     (2)
where
•	 Vincrease = volume increase of the orbital cavity due to 
deformation of the reconstruction material (m3).
•	 h = deformation of the disk-shaped implant (m).
•	 r = 0.0098 (m); this is the radius of a circular orbital 
floor defect measuring 3.0 cm2.
The changes in orbital volume give an indication of the 
suitability of the different implants for reconstruction of 
orbital floor defects in sheep. An increase in orbital volume 
of no more than 0.7 cm3 is considered the maximum 
allowable volume increase, as a larger increase in volume 
can lead to enophthalmos (Ploder et al., 2002; Van 
Leeuwen et al., 2012a).
Results
During the in vivo experiment, none of the sheep showed 
signs of infection or adverse tissue reactions. One 
(otherwise healthy) animal died unexpectedly 6 months 
postoperatively. A performed autopsy did not reveal an 
obvious cause of death. No animals were excluded from 
this study, and the prematurely deceased animal was 
evaluated as a separate 6-month time point group.
Descriptive microscopy of intramuscular 
implantations
After 3 and 9 months, all intramuscularly implanted 
specimens were harvested. Table 2 gives an overview of the 
bone incidence observed. Light microscopical evaluation 
of the stained sections showed that bone formation had 
occurred when BCP particles or BCP-containing materials 
were implanted. Implantations of PTMC sheets that did not 
contain BCP particles did not lead to formation of bone 
in any of the sheep.
 Fig. 1 gives an overview of the intramuscularly 
implanted materials after 3 months. Light microscope 
observations showed that, when present, bone had formed 
around the BCP particles. The BCP particles were in 
close contact with the newly formed bone. Ingrowth of 
connective tissue was also observed. It was shown that for 
the implanted PTMC/BCP composites the PTMC polymer 
matrix had degraded profoundly and only small amounts of 
the polymer could be identified. Of the laminated PTMC/
BCP-PDLLA composite, the PDLLA component could 
still be seen at this time point. In the implantations of the 
PTMC sheets (not containing BCP) no bone was formed. 
The remaining PTMC was surrounded by a fibrous capsule 
of dense connective tissue. Besides signs of polymer 
degradation, also disintegration of the BCP particles was 
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observed. In Fig. 2 the degradation of the polymeric PTMC 
matrix and the disintegration of the BCP particles is shown 
at higher magnifications. The highest magnifications 
showed the recruitment of phagocytic and multi-nucleated 
giant cells. These cells adhered to the surface of remnants 
of PTMC polymer and to the BCP particles.
 Histological images of the intramuscularly implanted 
materials at 9 months are available as supplementary 
information. After 9 months, the implantation of the 
BCP particles had led to progressive bone formation. By 
contrast, ectopically formed bone upon implantation of 
the PTMC/BCP composites and the PTMC/BCP-PDLLA 
laminated composite could not be discerned at this time 
point. The polymeric components of the composites had 
resorbed almost completely. Only few phagocytosed PTMC 
particles could be observed. Signs of disintegration of the 
BCP particles were seen. The intramuscularly implanted 
PTMC sheets were still identifiable, although degradation 
had progressed. The remaining material was surrounded 
by a fibrous capsule consisting of dense connective tissue.
Descriptive microscopy of the orbital implantations
The results of the evaluations of the orbital implantations 
are shown in Table 2 and Fig. 3.  After 3 months, the 
composite implants and the laminated composites clearly 
showed the formation of bone. Most of the polymeric 
PTMC matrix had degraded at this time, and only small 
remnants of the polymer could be observed. The newly 
formed bone was in close contact to the BCP particles that 
had now become available. Following the implantation of 
the composite implants, the newly formed bone showed 
osseous integration with the host bone at places where the 
implants were in contact with the host bone (i.e., at the 
orbital floor defect borders), see Fig. 4. At the site of the 
defect, where the composite implants were not in contact 
with host bone, several layers of dense connective tissue 
covered the degrading implants. However, bone had also 
formed in regions where the implant covered the defect; 
this is shown in Fig. 3B and 3H.
 The PTMC/BCP-PDLLA laminated composites, by 
contrast, did not show this osseous integration of newly 
formed bone with host bone. These were completely 
surrounded by a fibrous capsule composed of dense 
connective tissue (Fig. 4).
 After 9 months, the bone formation appeared to be 
progressive for the PTMC/BCP composite implants. In 
some animals, bone almost bridged the defect (Fig. 3H). 
Both the PTMC/BCP composite implants and the PTMC/
BCP-PDLLA laminated composite implants showed 
almost complete resorption of the polymeric PTMC matrix. 
Only some remaining phagocytosed PTMC polymer 
material could be discerned. The PDLLA layer seemed to 
have been resorbed completely at 9 months. Whereas the 
newly formed bone in the composite implants still showed 
integration with the host bone at this time point, the PTMC/
BCP-PDLLA laminated composites remained surrounded 
by a fibrous capsule and subsequently did not show osseous 
integration.
 Signs of disintegration of the BCP particles were also 
seen after the 9-month implantation period. Fig. 5 shows a 
PTMC/BCP composite implant and a PTMC/BCP-PDLLA 
laminated composite implant after 3 and 9 months at higher 
magnifications.
 The histological findings for the animal that died after 
6 months were comparable to the observations found 
for the other animals after 9 months. In this animal, the 
orbital PTMC/BCP composite implant showed new bone 
formation that had integrated with the host bone. Although 
the PTMC/BCP-PDLLA laminated composite implant 
placed in the other orbit did show bone formation, the 
newly formed bone (again) had not integrated with the 
host bone. A fibrous capsule surrounded the laminated 
composite implant. Besides the intramuscularly implanted 
BCP particles, none of the intramuscular composite 
material implantations lead to ectopic bone formation (see 
Table 2). At 6 months the degradation and resorption of the 
PTMC polymer matrix and the PDLLA layer was shown 
to be progressive when compared to 3-month implants. 
However, the degradation was not as advanced as in the 
9-month groups. Remnants of the PDLLA layer could 
still be identified. Disintegration of the BCP particles was 
observed when BCP or (laminated) BCP composites were 
implanted.
Fluorescence microscopy
Epifluorescent confocal microscopy of the sequential 
fluorochrome labels revealed that 3 weeks after 
implantation the formation of bone had started in the 
intramuscular implantations of the BCP particles and 
Implanted material
Bone incidence
3 months % new bone 
Bone incidence
6 months % new bone
Bone incidence
9 months % new bone
BCP particles IM: 2/5 2.9 ±5.9 IM: 1/1 12.8 IM: 2/4 6.4 ±6.9
PTMC OF: 0/3
IM: 0/3
0 ±0
0 ±0
NI
NI
OF: 0/3
IM: 0/3
0 ±0
0
PTMC/BCP composite OF: 3/4
IM: 2/4
7.7 ±8.1
0.3 ±0.6
OF: 1/1
IM: 0/1
14.9
0
OF: 3/3
IM: 0/3
15.7 ±14.6
0
PTMC/BCP-PDLLA 
laminated composite
OF: 3/3
IM: 2/3
5.3 ±4.0
2.0 ±1.9
OF: 1/1
IM: 0/1
13.9
0
OF: 1/2
IM: 0/2
1.7 ±2.4
0
Table 2: Bone incidence upon implantations after 3, 6 and 9 months and concomitant percentages of the amount of 
new bone formed in the available area as determined by histomorphometry. Mean ±SD is presented.
OF: orbital floor
IM: intramuscular
NI: not implanted
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Fig. 1. Light micrographs of intramuscular implantation sites after 3 months. A-D represent overviews of intramuscular 
implantations of respectively BCP, PTMC/BCP composite, PTMC/BCP-PDLLA laminated composite and PTMC. 
E-F represent magnifications (4x) of the corresponding marked regions: image E is a magnification of A, image 
F of B, etc. Bone (b) is clearly visible and surrounds the BCP particles (p) in Figs. 1 A-C and their corresponding 
magnifications. The PTMC (●) matrix has degraded, however still phagocytosed polymeric material (arrows) can be 
observed. (▲) designates an area where remnants of disintegrated BCP particles are present. (■) PDLLA polymer. 
(Scale bar represents 100 µm). Note that the polymer is transparent in the microscopical sections, and thus shows 
white in the images.
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the (laminated) composites. Similar observations were 
found for the PTMC/BCP composite and the laminated 
PTMC/BCP-PDLLA composite implants in the orbital 
implantation experiments (Fig. 6). Colours for the labels 
were set as follows: calcein is green; xylenol orange is 
red; oxytetracycline is blue. Analysis of the fluorochrome 
labels indicated that the formation of bone had started at 
the surface of the BCP particles and progressed outwards. 
After 9 months, the fluorochrome labelling showed that 
the process of bone formation and remodelling was 
still active in the orbital floor implantations. None of 
the intramuscularly implanted (laminated) composites 
showed fluorescence after 9 months. The prematurely 
deceased animal had died before the fluorochromes were 
administered and did therefore not show fluorochrome 
fluorescence.
Fig. 2. Light micrographs of intramuscular implantations after 3 months of respectively pure BCP particles (A, B), 
PTMC/BCP composite (C, D) and PTMC/BCP-PDLLA laminated composite (E, F). BCP particles are surrounded 
by phagocytic cells. The dust-like aspect (*) at the surface of the particles (p) suggests their disintegration. Remaining 
PTMC material (indicated by the arrows) can clearly be identified. (b) bone. (Figs. 2A, C and E are 20x magnifications, 
Figs. 2B, D and F 40x). (Scale bars represent 50 µm).
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Histomorphometry
The results of the histomorphometrical analysis of the 
intramuscular and orbital implantation sites are shown in 
Table 2. The mean percentages and standard deviations are 
presented for the amount of bone formed in the available 
area. (The available area is defined as the space between 
the BCP particles where the polymer has resorbed). 
Not all animals showed bone formation following the 
implantations. Furthermore, when bone was present, large 
variations in the amounts of formed bone were observed 
in and between individual animals.
 After 3 months, measurements showed 7.7 ±8.1 % 
(mean ±SD) of bone had formed following the PTMC/
BCP composite orbital floor implantations. After 9 months, 
the percentage of bone had increased to 15.5 ±12.0 %. 
The PTMC/BCP-PDLLA laminated composite orbital 
floor implants showed 5.3 ±4.0 % and 1.7 ±2.4 % of 
bone formation, respectively after 3 and 9 months. The 
intramuscular implantations only showed limited bone 
formation. The intramuscularly placed PTMC/BCP 
composite samples showed 0.3 ±0.6 % and the PTMC/
BCP-PDLLA laminated composite 2.0 ±1.9 % of bone 
formation after 3 months. The intramuscularly placed 
amounts of BCP particles showed 2.9 ±5.9 % bone 
formation, which progressed to 6.4 ±6.9 % of bone after 
9 months.
 The prematurely deceased animal showed respectively 
13.9 % and 14.9 % of bone formation for the PTMC/BCP-
PDLLA laminated composite and PTMC/BCP composite 
implantations in the orbits. The intramuscularly implanted 
BCP particles resulted in 12.8 % bone formation.
Evaluation of the reconstructed orbital floor by cone 
beam CT (CBCT)
Fig. 7 graphically presents the evaluation process of the 
reconstruction of the orbital floors, and illustrates the 
performance of the different implants. It can be seen that 
the radio-opaque PTMC/BCP composite and PTMC/
BCP-PDLLA laminated composite sheets were easily 
identified. As described in the experimental part, the 
colour mapping shows the deviation of the reconstructed 
orbital floor compared to the preoperative intact orbital 
floor. The results for the deformation of the implants and 
the calculated changes in the concomitant orbital volumes 
are summarised in Table 3. It can be seen that the increase 
in the orbital volume of animals treated with the PTMC 
implants (implants not containing BCP) ranged from 
+0.16 to +0.23 cm3, after 3 and 9 months respectively. The 
Fig. 3. Light micrographs of orbital implantations after 3 (A-F) and 9 (G-L) months. D, G and J show reconstruction 
with the PTMC sheet. Capsule formation is visible (see CT area in images D and J), there is no sign of bone formation. 
New bone formation is clearly visible and in close contact with the BCP particles after 3 months in the PTMC/BCP 
composite sheet (B, E) and is progressive after 9 months (H, K). Note that bone is growing in/over the original defect 
area in H. The PTMC/BCP-PDLLA laminated composite sheet also showed bone formation around BCP particles 
after 3 months (C, F), however to a lesser extent than when compared to the composite sheet as shown in image B, 
 E, H and K. After 9 months limited bone formation was found as shown in image I and L.
Images D-F and J-L are 4x magnifications of respectively the corresponding marked regions in images A-C and G-I; 
(●) PTMC, (*) maxillary sinus, (b) bone, (p) BCP particle, (■) PDLLA polymer, (arrow) residual polymeric PTMC 
material, (ct) connective tissue. (Scale bar represents 100 µm.).
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Fig. 4: Light micrographs (2.5x) representing the transition area of the PTMC/BCP composite (A-D) and the PTMC/
BCP-PDLLA laminated composite (E-H) implant, to host (and newly formed) bone in the orbit of the sheep. B and D 
are respectively magnifications of the marked areas shown in A and C where the composite implants are in close contact 
with the host bone and show excellent osseous integration of newly formed bone with the host bone after respectively 3 
and 9 months. F and H are respectively magnifications of the areas shown in E and G where the laminated composite 
implants are in close contact with the host bone. F clearly illustrates the PDLLA layer of the laminated composite 
impeding osseous integration after 3 months. H shows that after 9 months, although the PDLLA layer has degraded, 
osseous integration of newly formed bone with the host bone still has not occurred. This could be due to the fibrous 
capsule that is present between the newly formed bone and the host bone. (b) bone, (p) BCP particle, (■) PDLLA 
polymer, (fc) fibrous capsule. (Scale bar represents 400 µm).
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Fig. 5. Light micrographs (20x) showing the disintegration of BCP particles following orbital implantations after 
3 and 9 months, respectively. A and B are sections of orbital PTMC/BCP composite implantations. C and D are 
sections of orbital PTMC/BCP-PDLLA laminated composite implants. The dust-like aspect (*) at the surface of 
the BCP particles (p) suggests they are disintegrating. Remaining PTMC material (arrows) is easily identified. The 
disintegration of the BCP particles in the composite and in the laminated composite tended to be more extensive when 
compared to the disintegration in the intramuscular implantations of BCP particles only. (*) shows an area containing 
disintegrating BCP, (arrow) phagocytosed PTMC material, (b) bone. (Scale bar represents 50 µm.).
PTMC
3 months 9 months
PTMC/BCP*
3 months 6 months 9 months
PTMC/BCP-PDLLA**
3 months 6 months 9 months
Deformation (mm) -0.77 ±0.25 -1.20 ±0.36 -0.48 ±0.79 -1.1 -0.67 ±0.25 -0.80 ±0.26 -0.7 -0.70 ±0.42
Vol. increase orbit (cm3) 0.12 ±0.04 0.18 ±0.06 0.10 ±0.08 0.16 0.10 ±0.04 0.13 ±0.04 0.11 0.11 ±0.07
Table 3: Mean negative deformations of the reconstructed orbital floors and after 3 and 9 months using different 
implant materials. The animal that died after 6 months is considered individually. The preoperative scan served as 
reference. Mean negative deformations ±SD are given in mm.
 The calculated increase in volume after 3, 6 and 9 months for the different reconstruction materials is also provided. 
Mean negative deformations ±SD are given in cm3. The increase in volume occurred due to deformation of the 
reconstruction materials. The defect size was considered to be 3 cm2.
* PTMC/BCP: composite
** PTMC/BCP-PDLLA: laminated composite
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Fig. 6 .  Epifluorescent 
confocal micrographs of 
intramuscularly implanted 
BCP (A-B) and PTMC/
BCP composite (C-D). E-F 
and G-H are images of 
orbital implantations of 
the PTMC/BCP composite 
after, respectively 3 and 9 
months. A, C, E and G are 
bright field images, B, D, 
F and H are corresponding 
epifluorescent images. By 
comparing micrographs 
of the same region of an 
unstained section under 
epifluorescent (B, D, F and 
H) and transmitted light (A, 
C, E and G), correlations 
between the composite and 
bone formation are possible. 
Calcein (C) = green, Xylenol 
Orange (XO) = red and 
Oxytetracycline(T) = blue. 
It can be seen that bone 
formation had star ted 
af te r  3  weeks  (green 
coloured zones) around the 
intramuscularly implanted 
BCP and  PTMC/BCP 
composite. The orbital 
implantat ions showed 
s imi lar  resul t s .  Bone 
formation had started after 
3 weeks (green coloured 
zones  in  E-F )  in  the 
3-month group. The blue 
coloured zones in G-H 
show the process of bone 
formation still being active 
at 9 months.
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animals treated with the PTMC/BCP composite implants 
showed an orbital volume increase that ranged from +0.14 
to +0.19 cm3, while the animals treated with the PTMC/
BCP-PDLLA laminated composite implants showed 
volume increases ranging from +0.11 to +0.15 cm3.
Discussion
The present study describes the evaluation of the 
osteoinductive properties of composite materials prepared 
from PTMC and microstructured BCP. The composite 
materials were evaluated both in an orthotopic (orbit), 
as well as in an ectopic (intramuscular) site in sheep. 
The sheep model is well known and has been thoroughly 
evaluated (Kontio et al., 2004). With the evaluation of 
the osteoinductive properties of the composite materials, 
the suitability of the composite materials to serve as a 
load-bearing material for orbital floor reconstruction was 
assessed. From the results of this first study, it seems that 
PTMC/BCP composite materials and PDLLA-laminated 
PTMC/BCP composite materials have osteoinductive 
properties and can therefore be suited for use in the 
reconstruction of critical size orbital floor defects in sheep. 
Moreover, fluorochrome labelling indicates new bone 
formation that could be the result of osteoinductivity and 
or remodelling processes.
 To our knowledge this is not only the first report on 
the in vivo evaluation of osteoinductive solid composites 
composed of a continuous PTMC phase and a dispersed 
(biphasic) calcium phosphate particle phase, but it is also 
the first report on synthetic resorbable osteoinductive 
composites for use in orbital floor reconstruction.
 The first clinical use of resorbable polymeric implants 
in the management of orbital floor fractures was reported 
by Cutright and Hunsuck (1972), who used poly(lactic 
acid) implants to reconstruct orbital floor fractures. Since 
then, several studies evaluating poly(lactic acid) as a 
reconstruction material in orbital floor fractures have been 
conducted (Rozema et al., 1990; Bergsma et al., 1994; 
Kontio et al., 2004; Baino, 2011).
 In the early 1970s, calcium phosphates were also used 
to repair bone defects in craniomaxillofacial surgery (Levitt 
et al., 1969, Monroe et al., 1971). Although their use led 
to bony regeneration of the fractured orbital floor (Mathur 
et al., 2003, Sinikovic et al., 2007), problems regarding 
the shaping of the brittle calcium phosphate implants were 
encountered. This led to postoperative enophthalmos in a 
significant number of patients (Nam et al., 2006).
 Downes and Tanner (Tanner et al., 1994) reported on 
an osteoconductive composite for the treatment of orbital 
floor fractures that was based on hydroxyapatite and 
polyethylene (HAPEX). This composite did demonstrate 
neither osteoinductive properties nor signs of degradation. 
In addition, the limitations of ceramic materials regarding 
shape-ability were recognised, in particular in the 
reconstruction of orbital floor fractures.
 During the surgical procedures in our study, it became 
clear that the shape-ability of the PTMC implants 
was excellent. In addition, the PTMC composite and 
laminated composite implants were relatively flexible 
and not brittle at all, and could be easily cut into a desired 
shape. Furthermore, our results showed that both the 
composite and the laminated composite implants exerted 
osteoinductive properties. The composite implants showed 
excellent osseous integration of the newly formed bone 
Fig. 7. Assessment of orbital floor position. A shows a lateral view of a postoperative CBCT scan of a sheep. The 
PTMC/BCP composite implant (arrow) is radio-opaque and can be clearly identified at the top of the maxillary sinus 
(*). B shows the superposition of the postoperative scan over the preoperative scan. The region of interest is highlighted. 
The colour mapping is shown. There is a slight ‘negative’ deformation at the centre of the implant when compared 
to the preoperative situation. Where the implant overlies the defect borders (i.e. is resting on the intact orbital floor 
borders), the deformation is slightly ‘positive’ when compared to the preoperative situation of the intact orbital floor.
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with the host bone. At the defect site, where the composite 
implants were not in contact with host bone, even new 
bone formation that almost bridged the defect was 
demonstrated. Although such findings have been reported 
previously (Rozema et al., 1990; Kontio et al., 2004) 
this is nevertheless of great importance for the long-term 
results as the composite implants are resorbable and bony 
regeneration of the orbital floor at the defect site is the 
main target.
 The histological observations of the degradation of the 
polymeric PTMC matrix with simultaneous formation of 
bone supported our hypothesis that a resorbable polymeric 
matrix could enhance the mechanical properties of 
calcium phosphate ceramics, without negatively affecting 
the osteoinductive properties of the calcium phosphate 
particles. For the laminated composites, however, the 
PDLLA layer might have exerted a negative effect on bone 
formation and osseous integration of newly formed bone 
with host bone in two ways: firstly, by creating a physico-
mechanical barrier between the composite and host bone 
and secondly, by inducing an acidic environment during 
degradation which can have detrimental effects on host 
bone and bone formation (Taylor et al., 1994; Wu and 
Ding, 2004).
 Osseous integration might also have been impeded 
by the fibrous capsule, which surrounded the degrading 
laminated composites. Formation of a fibrous capsule 
around (resorbable) biomaterials occurs when the surface-
to-volume ratio of the implanted biomaterial is unfavourably 
low, or when the implanted biomaterial impedes or hinders 
the regeneration of normal tissues (Anderson and Shive, 
1997; Ratner et al., 2004)). This could explain the fact 
that while remnants of the orbitally implanted PTMC/
BCP composite implants were not completely surrounded 
by a fibrous capsule, remnants of the (orbitally implanted) 
PTMC/BCP-PDLLA laminated composite implants and 
the PTMC implants were completely encapsulated. Both 
the PTMC and the PDLLA layer might have hindered the 
regeneration of normal tissue. The PTMC/BCP composites 
did not hinder the regeneration of normal/local tissue as 
their use led to excellent osseous integration. Since the 
degradation process can progress along the surface of 
exposed BCP particles, the surface-to-volume ratio can 
be expected to increase favourably.
 The histological observation of the disintegration of 
BCP particles (also in composites) has been reported 
previously (Benahmed et al., 1996; Dupraz et al., 1998; 
Dupraz et al., 1999; Gauthier et al., 1999; Fellah et al., 
2010). Dupraz et al. developed a composite of BCP 
and a degradable cellulosic ether (Dupraz et al., 1998). 
The result from their in vivo study in rabbits revealed 
that phagocytosis upon implantation of the composites 
and of the BCP particles themselves was mediated by 
macrophages and giant multinucleated cells.  Since these 
cells play a major role in the degradation process of PTMC 
(Pego et al., 2003b; Bat et al., 2010) it is most likely 
that macrophages and giant multinucleated cells also are 
involved in the BCP disintegration process observed in our 
experiments.
 The large variations in the amounts of induced bone that 
we observed in and between the individual animals are not 
uncommon in research on osteoinductive materials. It is 
known that, besides animal-specific factors, implantation 
site-specific factors can also have an effect on the amount 
of induced bone (Habibovic et al., 2006; Yuan et al., 
2006a; Yuan et al., 2006b). Implantations in orthotopic 
locations tend to result in larger amounts of induced bone 
than implantations in ectopic locations (Habibovic et al., 
2006). In addition, it is suggested that the intrinsic ability 
of individual animals to form new bone in osteopromotive 
environments could vary as a result of genetic factors 
which in the process of osteoinduction can lead to different 
responses (Geesink et al., 1999; Marusic et al., 1999; 
Habibovic et al., 2005). As we used non-inbred Texel 
sheep, genetic variation can be expected to be present.
 The evaluation by CBCT showed that all the 
reconstructed orbital floors were adequately positioned 
as compared with the preoperative anatomical situation. 
None of the maximum calculated increases in volume of 
the orbits that result from deformation of the implants were 
larger than the aforementioned critical value of 0.7 cm3 (see 
Table 3). In the treatment of orbital floor fractures with 
resorbable materials, the main short-term goal is to obtain 
a stiff scar composed of a dense connective tissue capsule. 
This scar prevents the orbital content from sagging into 
the maxillary sinus during degradation or resorption of the 
implant (Enislidis, 2004). It should be noted however, that 
complications at the long-term (such as late enophthalmos) 
are not always prevented by the formation of such fibrous 
capsule, and ideally bone is regenerated at the level of 
the orbital floor defect. In this respect, the PTMC/BCP 
composite and PTMC/BCP-PDLLA laminated composite 
showed promising results. Nonetheless, future research on 
the outcomes at the long-term will need to be conducted. 
The question whether the regenerated bone will become 
a regenerated bony orbital floor that is in contact with 
the host bone and capable of keeping the orbital content 
in position and prevent late on-set enophthalmos will be 
addressed.
Conclusions
The present study describes the preparation and in vivo 
evaluation of osteoinductive composites composed of 
PTMC and microstructured BCP particles for use in orbital 
floor reconstruction. Composites were also laminated with 
PDLLA. From the obtained data it can be concluded that 
the composite materials are shapeable, exert osteoinductive 
properties and are likely very well suited for use in the 
bone-regenerating reconstruction of orbital floor fractures 
in sheep. Furthermore, excellent osseous integration of the 
newly formed bone with the host bone was observed, after 
9 months bone almost bridged the defects reconstructed 
with the PTMC/BCP composite materials.
 Future research focussing on the long-term performance 
as well as improvement of the osteoinductive properties of 
these promising composite materials will be performed, and 
definitive conclusions regarding their bone regenerating 
capacity and suitability as reconstruction material in 
the treatment of orbital floor fractures will be drawn. In 
addition, based on the favourable results of the present 
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study, the preparation of other PTMC composites with bone 
forming-components such as Bioglass, can be considered 
as well.
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Discussion with Reviewers
A. Bernstein: While the ectopic bone formation by the 
composites at 3 months certainly implies that they possess 
some degree of osteoinductivity, the reviewer is not 
convinced that the addition of polymeric phase does not 
negatively impact the osteoinductivity of the BCP. This is 
primarily due to the fact that the BCP particles consistently 
demonstrated ectopic osteoinduction, while the BCP/
polymer composites demonstrated only sporadic ectopic 
bone formation (presumably in the same animals). While 
the BCP/polymer composites did show bone formation at 
intraorbital sites, this could be due to osteoconduction (as 
evidenced by apparent low bone formation in surfaces not 
in contact with host bone) along with osteoinduction. This 
is further evidenced by the fact that there is lower bone 
formation in the PDLLA group in which the PDLLA serves 
as an initial barrier between the embedded BCP particles 
and host bone.
Authors: In the ectopic implantations of BCP, relatively 
large amounts of the ceramic induce bone formation. 
When implanting the composite materials, it should be 
realised that (1) much smaller amounts of the ceramic BCP 
phase are present and (2) these particles will only be able 
to induce bone formation upon erosion of the polymeric 
phase. Furthermore, at 6 and 9 months after intramuscular 
implantation both the polymer and the PTMC/BCP 
composites had almost completely resorbed, while in the 
case of BCP implantations BCP particles were still present 
at these time points due to the much larger amount initially 
implanted (see Fig. 8). Although osteoconduction and 
osteoinduction can occur simultaneously during the repair 
of the orbital floor, it is interesting to see in Fig. 3 H that 
new bone has formed after 9 months at the centre of the 
implant (i.e., not in close contact with the host bone). For 
these reasons, we do not reach the same conclusion as the 
reviewer. In our opinion, the degrading polymer phase does 
not negatively influence the osteoinductive performance 
of the BCP phase, although we have not performed the 
experiment in which equal amounts of BCP and BCP in a 
PTMC/BCP composite were implanted.
A. Bernstein: Can the authors comment on possible 
synergestic effects of polymer resorption products and 
dynamic dissolution-reprecipitation of the BCP particles? 
Could the degradation products from PTMC/PDLLA 
influence osteoinductive properties of the BCP particles?
Authors: While it is known that the most often used 
lactide and glycolide (co)polymers can produce significant 
amounts of acidic compounds during degradation in the 
body, and that calcium phosphate ceramics and more 
importantly bone dissolve in acidic environments, it can 
be expected that these polymers will not be the most 
suitable matrix materials. In contrast, PTMC polymers 
do not produce acidic degradation products and therefore 
are likely to maintain osteoinductive properties. Besides 
its surface eroding properties, which allow the exposure 
and liberation of the osteoinductive particles during the 
degradation process, this was one of the main reasons for 
using PTMC in the composites.
A. Bernstein: Do the authors have any suggestions 
by which the polymeric phase could be further tuned 
to enhance or accelerate the defect healing? This is 
particularly intriguing based on the authors’ proposal to 
study such composites with other ceramics as well.
Authors: As described in our previous work, the 
degradation rate of the PTMC matrix can be tuned by: (1). 
varying the molecular weight of the starting polymer, (2) 
varying the degree of crosslinking by adjusting the gamma 
irradiation dosage or (3) by preparing copolymers with a 
lactone such as ε-caprolactone. An appropriate preparing of 
copolymers with a lactone such that the degradation rate of 
the polymer will allow for sufficient scar tissue formation, 
since this is the main short term goal in orbital floor 
reconstruction. In addition, it would be of great interest 
to prepare a composite with higher BCP contents that still 
possesses good mechanical and handling properties.
D. Bosshardt: What was the reason for using the sheep 
for the testing of both ectopic bone formation and orbital 
floor reconstruction (OFR)?
Authors: Sheep models have often been used to assess 
bone formation experimentally. With regard to the orbit, 
the orbital volume of the sheep is larger than that of the 
human. This implies that the weight of its contents (eyeball, 
fat and muscles) will also be higher, putting higher loads 
on the orbital floor implant. From a mechanical point of 
view we can expect that when an implant performs well in 
a sheep model, it will also do so in humans. Nevertheless, 
it will remain necessary to conduct human trials as well.
D. Bosshardt: Can one expect that when a material 
is osteoinductive in sheep, it is also osteoinductive in 
humans?
Authors: The exact mechanism of osteoinduction by 
biomaterials is still incompletely understood. Currently it 
is known that the osteoinductivity of biomaterials is species 
and animal dependent: in small animals like rodents, bone 
is rarely induced by synthetic biomaterials. By contrast, 
bone formation is much more frequently observed in larger 
(sheep, goat, dogs) and higher (i.e., non-human primates) 
animals (Ripamonti (1996) text reference; Barradas et al. 
(2011) text reference).
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Fig. 8: Light micrographs of intramuscular implantation sites after 9 months. Images A-D represent details of 
intramuscular implantations of respectively BCP, PTMC/BCP composite, PTMC/BCP-PDLLA laminated composite 
and PTMC after 9 months. E-H represent overviews of the corresponding marked regions in image A-D. Bone 
formation upon implantation of the PTMC/BCP composites and the PTMC/BCP-PDLLA laminated composite could 
not be discerned at 9 months. F and G show that the polymeric components of the composites as well as the ceramic 
component had resorbed almost completely. The intramuscularly implanted PTMC sheets were still identifiable, 
although degradation had much progressed. The remaining material was surrounded by a fibrous capsule consisting of 
dense connective tissue. In accordance with Fig. 1, the black dots represent the BCP particles, also PDLLA polymer 
(■) and PTMC polymer (●) can be discerned.
